surmount-1 trial tirzepatide obesity without diabetes weight loss once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 π€Adults with type 2 diabetes
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 8 - Oct 13



























